Loading clinical trials...
Loading clinical trials...
Sulforaphane in Autism: A Treatment Trial to Confirm Phenotypic Improvement With Sulforaphane Treatment in a New Jersey (NJ) Population of Individuals With Autism
Conditions
Interventions
Sulforaphane
Placebo
Locations
1
United States
Rutgers University - Staged Research Building
Piscataway, New Jersey, United States
Start Date
February 1, 2016
Primary Completion Date
December 1, 2025
Completion Date
March 1, 2026
Last Updated
October 29, 2025
NCT06290258
NCT00271622
NCT05750095
NCT06329245
NCT05874466
NCT06712784
Lead Sponsor
Rutgers, The State University of New Jersey
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions